Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Analysts Sound Alarm On Pyxis Oncology's Tiny Trial
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside